A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study to assess the efficacy of SB1518 in the treatment of patients with
advanced lymphoid malignancies including Hodgkin Lymphoma, Mantle Cell Lymphoma and Indolent
Lymphoma (follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small
lymphocytic lymphoma).